Funding for this research was provided by:
the Key Technology Research and Development Program of Science and Technology, Tianjin (18ZXDBSY00210)
Research and promotion project of appropriate technology for intervention of high risk population of stroke in China (2020R0005)
Clinical Medicine Research Project of the Second University of Tianjin Medical University (2020LC04)
Article History
Received: 10 August 2021
Accepted: 14 September 2021
First Online: 28 September 2021
Declarations
:
: Our study was approved by The Second Hospital of Tianjin Medical University Ethics Committee and the informed consents were not needed to sign.
: All authors consent to the publication of this manuscript; additional consent is not applicable.
: The author reports no conflicts of interest in this work.